nodes	percent_of_prediction	percent_of_DWPC	metapath
Dobutamine—COMT—Clearance of dopamine—SLC6A3—Gilles de la Tourette syndrome	0.222	0.237	CbGpPWpGaD
Dobutamine—COMT—Biogenic Amine Synthesis—HDC—Gilles de la Tourette syndrome	0.176	0.188	CbGpPWpGaD
Dobutamine—COMT—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—Gilles de la Tourette syndrome	0.101	0.108	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0219	0.0234	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0215	0.0229	CbGpPWpGaD
Dobutamine—Dopamine—DRD4—Gilles de la Tourette syndrome	0.0198	0.307	CrCbGaD
Dobutamine—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0187	0.02	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0183	0.0196	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0182	0.0194	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0178	0.019	CbGpPWpGaD
Dobutamine—Dopamine—DRD3—Gilles de la Tourette syndrome	0.0171	0.264	CrCbGaD
Dobutamine—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0169	0.0181	CbGpPWpGaD
Dobutamine—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0165	0.0177	CbGpPWpGaD
Dobutamine—Dopamine—SLC6A3—Gilles de la Tourette syndrome	0.0159	0.246	CrCbGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0157	0.0168	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0154	0.0164	CbGpPWpGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0153	0.0163	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0149	0.016	CbGpPWpGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0142	0.0152	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0139	0.0149	CbGpPWpGaD
Dobutamine—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0118	0.0127	CbGpPWpGaD
Dobutamine—Dopamine—DRD2—Gilles de la Tourette syndrome	0.0118	0.183	CrCbGaD
Dobutamine—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0116	0.0124	CbGpPWpGaD
Dobutamine—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00996	0.0106	CbGpPWpGaD
Dobutamine—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.00985	0.0105	CbGpPWpGaD
Dobutamine—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00974	0.0104	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00813	0.00869	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00789	0.00843	CbGpPWpGaD
Dobutamine—CA5A—Metabolism—HDC—Gilles de la Tourette syndrome	0.00771	0.00824	CbGpPWpGaD
Dobutamine—COMT—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0077	0.00823	CbGpPWpGaD
Dobutamine—CA5B—Metabolism—HDC—Gilles de la Tourette syndrome	0.0072	0.00769	CbGpPWpGaD
Dobutamine—COMT—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.0059	0.00631	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00515	0.0055	CbGpPWpGaD
Dobutamine—CA2—Metabolism—HDC—Gilles de la Tourette syndrome	0.0051	0.00545	CbGpPWpGaD
Dobutamine—COMT—Metabolism—HDC—Gilles de la Tourette syndrome	0.00427	0.00457	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00361	0.00386	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00353	0.00377	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0035	0.00375	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00343	0.00366	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00326	0.00349	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00319	0.00341	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00309	0.00331	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00302	0.00323	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.003	0.00321	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00294	0.00314	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0028	0.00299	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00274	0.00292	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00235	0.00252	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0023	0.00246	CbGpPWpGaD
Dobutamine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00229	0.00244	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00229	0.00244	CbGpPWpGaD
Dobutamine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00224	0.00239	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00224	0.00239	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00213	0.00228	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00208	0.00223	CbGpPWpGaD
Dobutamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00196	0.00209	CbGpPWpGaD
Dobutamine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00192	0.00205	CbGpPWpGaD
Dobutamine—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00149	0.00159	CbGpPWpGaD
Dobutamine—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00146	0.00156	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00133	0.00142	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0013	0.00139	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00129	0.00138	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00126	0.00135	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00121	0.00129	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0012	0.00129	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00118	0.00126	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00118	0.00126	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00117	0.00125	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00115	0.00123	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00109	0.00117	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00107	0.00114	CbGpPWpGaD
Dobutamine—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000843	0.000901	CbGpPWpGaD
Dobutamine—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000824	0.000881	CbGpPWpGaD
Dobutamine—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000765	0.000818	CbGpPWpGaD
Dobutamine—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000749	0.0008	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000714	0.000763	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000698	0.000747	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000693	0.000741	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000678	0.000725	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000646	0.00069	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000631	0.000675	CbGpPWpGaD
Dobutamine—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000452	0.000483	CbGpPWpGaD
Dobutamine—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000442	0.000473	CbGpPWpGaD
